tradingkey.logo
tradingkey.logo
검색

Haleon PLC

HLN
관심 목록에 추가
9.110USD
-0.185-1.99%
종가 05/08, 16:00ET시세는 15분 지연됩니다
40.08B시가총액
33.07P/E TTM

Haleon PLC

9.110
-0.185-1.99%

자세한 내용은 Haleon PLC 회사

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Haleon PLC 정보

종목 코드 HLN
회사 이름Haleon PLC
상장일Jul 18, 2022
CEOMcnamara (Brian)
직원 수- -
유형Depository Receipt
회계 연도 종료Jul 18
주소Building 5, First Floor
도시WEYBRIDGE
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United Kingdom
우편 번호KT13 0NY
전화441932822000
웹사이트https://www.haleon.com/
종목 코드 HLN
상장일Jul 18, 2022
CEOMcnamara (Brian)

Haleon PLC의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

수익 분석

통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Oral health
3.46B
31.38%
Pain relief
2.56B
23.25%
Respiratory health
1.87B
16.98%
Vitamins, minerals and supplements
1.69B
15.28%
Digestive health and other
987.00M
8.95%
Therapeutic Skin Health and Other
460.00M
4.17%
지역별USD
이름
수익
비율
Rest of the World
6.19B
56.11%
EMEA and LatAm
4.59B
41.63%
Northern America
3.87B
35.05%
US & Puerto Rico
3.47B
31.44%
APAC
2.57B
23.32%
기타
-9.66B
-87.55%
사업별
지역별
사업별USD
이름
수익
비율
Oral health
3.46B
31.38%
Pain relief
2.56B
23.25%
Respiratory health
1.87B
16.98%
Vitamins, minerals and supplements
1.69B
15.28%
Digestive health and other
987.00M
8.95%
Therapeutic Skin Health and Other
460.00M
4.17%

주식 보유 통계

마지막 업데이트: Fri, Apr 24
마지막 업데이트: Fri, Apr 24
주주
주주 유형
주주
주주
비율
Dodge & Cox
3.42%
Fidelity Management & Research Company LLC
2.08%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
기타
93.06%
주주
주주
비율
Dodge & Cox
3.42%
Fidelity Management & Research Company LLC
2.08%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.37%
Norges Bank Investment Management (NBIM)
0.36%
기타
93.06%
주주 유형
주주
비율
Investment Advisor
5.54%
Investment Advisor/Hedge Fund
5.37%
Research Firm
0.86%
Hedge Fund
0.64%
Sovereign Wealth Fund
0.36%
Bank and Trust
0.17%
Family Office
0.06%
Family Office
0.06%
Family Office
0.06%
기타
86.87%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
1090
575.83M
12.97%
+12.05M
2025Q4
1068
546.97M
12.28%
-32.09M
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Dodge & Cox
151.76M
3.4%
-2.63M
-1.70%
Dec 31, 2025
Fidelity Management & Research Company LLC
92.14M
2.07%
+3.03M
+3.39%
Dec 31, 2025
ClearBridge Investments, LLC
31.42M
0.7%
-1.92M
-5.77%
Dec 31, 2025
Harding Loevner LP
16.62M
0.37%
-1.29M
-7.22%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
16.18M
0.36%
+15.90M
+5781.82%
Dec 31, 2025
Fidelity Institutional Asset Management
12.09M
0.27%
+701.80K
+6.16%
Dec 31, 2025
Sculptor Capital Management, Inc
10.45M
0.23%
+505.00K
+5.08%
Dec 31, 2025
Ostrum Asset Management
10.00M
0.22%
+8.12M
+429.78%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
9.23M
0.21%
+1.53M
+19.85%
Dec 31, 2025
Parametric Portfolio Associates LLC
8.24M
0.18%
+681.07K
+9.01%
Dec 31, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
VanEck Pharmaceutical ETF
6.34%
Franklin ClearBridge Enhanced Income ETF
1.87%
One Global ETF
0.65%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.27%
Avantis Responsible International Equity ETF
0.13%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
더 보기
VanEck Pharmaceutical ETF
비율6.34%
Franklin ClearBridge Enhanced Income ETF
비율1.87%
One Global ETF
비율0.65%
ActivePassive International Equity ETF
비율0.33%
SP Funds S&P World (ex-US) ETF
비율0.27%
Avantis Responsible International Equity ETF
비율0.13%
Avantis International Equity ETF
비율0.08%
Avantis International Large Cap Value ETF
비율0%
Unusual Whales Subversive Democratic Trading ETF
비율0%
Fidelity Blue Chip Value ETF
비율0%

주식 배당금

지난 5년 동안 총 570.00M USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 26, 2026
HLN.NB Approximate final Cash Dividend of gross USD 0.130732 paid on May 14, 2026 going ex on Apr 10, 2026
Apr 10, 2026
May 14, 2026
Apr 10, 2026
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI